Terry Lairmore, MD
Surgical Oncology · Shreveport, LANPI 1083674949
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,000 of the $13,466 with a category attached, or 74.3%. Intuitive Surgical accounts for 90.1% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $11,671 and has fallen 95.3% since, to $549 in 2025. Among surgical oncology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $204.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- Johnson & Johnson$290
- Lilly USA, LLC$232
- AbbVie$124
- Acera Surgical, Inc.$74
- AstraZeneca$69
- plus $537 from 21 others
What the payments were for
- Travel & lodging$1,46111%
- Food & beverage$2,00615%
- Education$10,00074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 28 | $12,140 |
| Johnson & Johnson | 5 | $290 |
| Lilly USA, LLC | 3 | $232 |
| AbbVie | 1 | $124 |
| Acera Surgical, Inc. | 2 | $74 |
| AstraZeneca | 3 | $69 |
| Merck | 2 | $54 |
| Eli Lilly | 1 | $54 |
| Tempus AI, Inc | 2 | $46 |
| Genentech USA, Inc. | 2 | $39 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Abiomed | 1 | $27 |
| Novartis | 1 | $25 |
| Menarini Silicon Biosystems, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Gilead | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Geron Corporation | 1 | $17 |
| Seagen Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Merit Medical Systems Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,466 in reported general payments places this provider in the 90th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Shreveport
- Julie CuppShreveport$2K
- Kevin MarlerShreveport$678
- Emery MinnardGretna$183K
- Mary Hobbs-MaluccioMetairie$41K
- Peter BostickBaton Rouge$7K
- Nathan BoltonNew Orleans$6K
- Lindsey FauveauBaton Rouge$4K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
- Amy RivereNew Orleans$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.